| 000 | 01609 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512002425.0 | ||
| 264 | 0 | _c19890103 | |
| 008 | 198901s 0 0 ger d | ||
| 022 | _a0300-5860 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGülker, H | |
| 245 | 0 | 0 |
_a[Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide]. _h[electronic resource] |
| 260 |
_bZeitschrift fur Kardiologie _cSep 1988 |
||
| 300 |
_a587-94 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xdrug therapy |
| 650 | 0 | 4 |
_aCardiac Complexes, Premature _xdrug therapy |
| 650 | 0 | 4 | _aCardiac Pacing, Artificial |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
| 650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 |
_aTachycardia _xdrug therapy |
| 700 | 1 | _aHeuer, H | |
| 700 | 1 | _aFrenking, B | |
| 700 | 1 | _aHaverkamp, W | |
| 700 | 1 | _aHindricks, G | |
| 700 | 1 | _aBozek, B | |
| 700 | 1 | _aBremkes, C | |
| 700 | 1 | _aAsche, K D | |
| 700 | 1 | _aWitthöft, D | |
| 773 | 0 |
_tZeitschrift fur Kardiologie _gvol. 77 _gno. 9 _gp. 587-94 |
|
| 999 |
_c2467645 _d2467645 |
||